CAS: 1263369-28-3
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | N2'-(trans-4-Aminocyclohexyl)-5'-chloro-N6-[(3-fluorophenyl)methyl]-[2,4'-bipyridine]-2',6-diamine REF: 3D-FA103213CAS: 1263369-28-3 | Min. 95% | A consultar | Ter 14 Jan 25 |
 | CDK9-IN-2 REF: TM-T14918CAS: 1263369-28-3 | 99% | 87,00 €~985,00 € | Ter 04 Fev 25 |
![N2'-(trans-4-Aminocyclohexyl)-5'-chloro-N6-[(3-fluorophenyl)methyl]-[2,4'-bipyridine]-2',6-diamine](https://static.cymitquimica.com/products/3D/thumb/FA103213.jpg)
N2'-(trans-4-Aminocyclohexyl)-5'-chloro-N6-[(3-fluorophenyl)methyl]-[2,4'-bipyridine]-2',6-diamine
CAS:1263369-28-3
N2'-(trans-4-Aminocyclohexyl)-5'-chloro-N6-[(3-fluorophenyl)methyl]-[2,4'-bipyridine]-2',6-diamine is a novel drug that has been shown to inhibit the growth of cancer …
Fórmula:
C23H25ClFN5
Pureza:
Min. 95%
Peso molecular:
425.93 g/mol
Ref: 3D-FA103213
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 14 de Janeiro de 2025
CDK9-IN-2
CAS:1263369-28-3
CDK9-IN-2, a CDK9 inhibitor from patent WO/2012131594A1, IC50: 5 nM in A2058, 7 nM in …
Fórmula:
C23H25ClFN5
Pureza:
99%
Cor e Forma:
Solid
Peso molecular:
425.93
Ref: TM-T14918
| 1mg | 87,00 € | ||
| 5mg | 185,00 € | ||
| 10mg | 278,00 € | ||
| 25mg | 481,00 € | ||
| 50mg | 697,00 € | ||
| 100mg | 985,00 € | ||
| 1mL*10mM (DMSO) | 204,00 € |
Entrega estimada em Estados Unidos, Terça-feira 4 de Fevereiro de 2025
